Protalix is a publicly traded biotechnology company (NYSE Amex: PLX), that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.

<< back to Press Releases

© 2007 Protalix Biotherapeutics. All Rights Reserved.